Vestor Capital’s Exact Sciences EXAS Stock Holding History

Vestor Capital’s Portfolio EXAS Stock Details EXAS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-675	Closed	-$46K	–	278
2024 Q3	$46K	Buy	+675	New	+$38.1K	﹤0.01%	237
2024 Q2	–	Sell	-675	Closed	-$47K	–	251
2024 Q1	$47K	Hold	675	–	–	﹤0.01%	242
2023 Q4	$50K	Hold	675	–	–	﹤0.01%	221
2023 Q3	$46K	Hold	675	–	–	0.01%	231
2023 Q2	$63K	Hold	675	–	–	0.01%	220
2023 Q1	$46K	Buy	+675	New	+$43.4K	0.01%	230
2022 Q2	–	Sell	-1,175	Closed	-$82K	–	217
2022 Q1	$82K	Hold	1,175	–	–	0.01%	160
2021 Q4	$91K	Buy	1,175 +500	+74%	+$44.1K	0.01%	160
2021 Q3	$64K	Hold	675	–	–	0.01%	185
2021 Q2	$84K	Hold	675	–	–	0.01%	151
2021 Q1	$89K	Hold	675	–	–	0.01%	147
2020 Q4	$89K	Buy	+675	New	+$81.6K	0.01%	140

Other funds holding EXAS

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Vestor Capital's EXAS Position: Q4 2024 in Review

Vestor Capital sold out of Exact Sciences (EXAS) in Q4 2024, closing a stake of 675 shares — an estimated $46K sold.

Vestor Capital first reported a position in EXAS in Q4 2020 and held it in 12 quarters. The position peaked at $91K in Q4 2021. 593 funds tracked by Wall St. Rank hold EXAS as of Q4 2024.

Vestor Capital reported no remaining Exact Sciences position as of Q4 2024 after selling out during the quarter.
Vestor Capital sold 675 Exact Sciences shares in Q4 2024, an estimated $46K.
Vestor Capital first reported a position in Exact Sciences in Q4 2020 and held it in 12 quarters.
Vestor Capital's Exact Sciences position peaked at $91K in Q4 2021.
593 funds tracked by Wall St. Rank held Exact Sciences as of Q4 2024.

Based on Vestor Capital's 13F filing for Q4 2024, filed 11 Feb 2025.